These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9108353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T, van der Eerden BC, Hoenderop JG, Weinans H, van Leeuwen JP, Bindels RJ.
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
    Van Beek ER, Löwik CW, Papapoulos SE.
    Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
    [Abstract] [Full Text] [Related]

  • 4. Alendronate reduces osteoclast precursors in osteoporosis.
    D'Amelio P, Grimaldi A, Cristofaro MA, Ravazzoli M, Molinatti PA, Pescarmona GP, Isaia GC.
    Osteoporos Int; 2010 Oct; 21(10):1741-50. PubMed ID: 19949772
    [Abstract] [Full Text] [Related]

  • 5. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W, Schot L, Ederveen A, van der Wee-Pals L, Papapoulos S, Löwik C.
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [Abstract] [Full Text] [Related]

  • 6. Effects of Alendronate and Dexamethasone on Osteoclast Gene Expression and Bone Resorption in Mouse Marrow Cultures.
    de Faria LP, Sueyoshi G, de Oliveira TC, Holliday LS, Arana-Chavez VE.
    J Histochem Cytochem; 2022 Feb; 70(2):169-179. PubMed ID: 34915746
    [Abstract] [Full Text] [Related]

  • 7. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo.
    Endo Y, Nakamura M, Kikuchi T, Shinoda H, Takeda Y, Nitta Y, Kumagai K.
    Calcif Tissue Int; 1993 Mar; 52(3):248-54. PubMed ID: 8481841
    [Abstract] [Full Text] [Related]

  • 8. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.
    Azuma Y, Sato H, Oue Y, Okabe K, Ohta T, Tsuchimoto M, Kiyoki M.
    Bone; 1995 Feb; 16(2):235-45. PubMed ID: 7756053
    [Abstract] [Full Text] [Related]

  • 9. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
    Weir EC, Lowik CW, Paliwal I, Insogna KL.
    J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
    [Abstract] [Full Text] [Related]

  • 10. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G, Yamamoto K, Nagashima M.
    Mod Rheumatol; 2006 Oct; 16(6):343-9. PubMed ID: 17164994
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC, Rogers MJ.
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro.
    Udagawa N, Chan J, Wada S, Findlay DM, Hamilton JA, Martin TJ.
    Bone; 1996 Jun; 18(6):511-6. PubMed ID: 8805990
    [Abstract] [Full Text] [Related]

  • 15. Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.
    Idris AI, Greig IR, Bassonga-Landao E, Ralston SH, van 't Hof RJ.
    Endocrinology; 2009 Jan; 150(1):5-13. PubMed ID: 18772231
    [Abstract] [Full Text] [Related]

  • 16. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
    Cao Y, Jansen ID, Sprangers S, Stap J, Leenen PJ, Everts V, de Vries TJ.
    J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
    [Abstract] [Full Text] [Related]

  • 17. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
    Frith JC, Mönkkönen J, Auriola S, Mönkkönen H, Rogers MJ.
    Arthritis Rheum; 2001 Sep; 44(9):2201-10. PubMed ID: 11592386
    [Abstract] [Full Text] [Related]

  • 18. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
    Samanna V, Ma T, Mak TW, Rogers M, Chellaiah MA.
    J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356
    [Abstract] [Full Text] [Related]

  • 19. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W, Grevers LC, Walgreen B, de Vries TJ, Leenen PJ, Everts V, Storm G, van den Berg WB, van Lent PL.
    J Control Release; 2011 Jun 30; 152(3):363-9. PubMed ID: 21396411
    [Abstract] [Full Text] [Related]

  • 20. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.
    Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T.
    Bone; 1995 Aug 30; 17(2):137-44. PubMed ID: 8554921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.